Farmacia Hospitalaria y Farmacogenómica

Morillo-Verdugo, R; Perez, TA; Gimeno-Gracia, M; Rodriguez-Gonzalez, C; Robustillo-Cortes, MD.

Simplification and Multidimensional Adaptation of the Stratification Tool for Pharmaceutical Care in People Living With HIV

ANNALS OF PHARMACOTHERAPY. 2023; 57(2): 163-174 Nº de citas: 7 [doi:10.1177/10600280221096759]

Ibarra Barrueta O; García Martín E; López Sánchez P; Ramírez Herráiz E; Merino Bohórquez V; Ais Larisgoitia A.

[Translated article] Biological and immunosuppressive medications in pregnancy, breastfeeding and fertility in immune mediated diseases.

FARMACIA HOSPITALARIA. 2023; 47(1): [doi:10.1016/j.farma.2022.12.016]

Salvador-Martin, S; Zapata-Cobo, P; Velasco, M; Palomino, LM; Clemente, S; Segarra, O; Sanchez, C; Tolin, M; Moreno-alvarez, A; Fernandez-Lorenzo, A; Perez-Moneo, B; Loverdos, I; Navas López VM; Millan, A; Magallares, L; Torres-Peral, R; Garcia-Romero, R; Pujol-Muncunill, G; Merino-Bohorquez, V; Rodriguez, A; Salcedo, E; Lopez-Cauce, B; Marin-Jimenez, I; Menchen, L; Laserna-Mendieta, E; Lucendo, AJ; Sanjurjo-Saez, M; Lopez-Fernandez, LA.

Association between HLA DNA Variants and Long-Term Response to Anti-TNF Drugs in a Spanish Pediatric Inflammatory Bowel Disease Cohort

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023; 24(2): Nº de citas: 9 [doi:10.3390/ijms24021797]

Gil-Manso, S; Blanco, IM; Motyka, B; Halpin, A; Lopez-Esteban, R; Perez-Fernandez, VA; Carbonell, D; Lopez-Fernandez, LA; West, L; Correa-Rocha, R; Pion, M.

ABO blood group is involved in the quality of the specific immune response anti-SARS-CoV-2

Virulence. 2022; 13(1): 30-45 Nº de citas: 10 [doi:10.1080/21505594.2021.2019959]

Taladriz-Sender, I; Manrique-Rodriguez, S; Fernandez-Llamazares, CM; Herranz-Alonso, A; Sanjurjo-Saez, M.

Standardisation of intravenous infusion therapy for paediatrics: big challenges for the little patients

EUROPEAN JOURNAL OF HOSPITAL PHARMACY. 2022; 31(3): 274-280 [doi:10.1136/ejhpharm-2022-003316]

Somoza-Fernandez, B; Ribed-Sanchez, A; Martin-Lozano, S; de Vega-San Vicente, FM; Menendez-Tarin, R; Gimenez-Manzorro, A; Sanz-Ruiz, P; Garutti-Martinez, I; Herranz-Alonso, A; Vaquero-Martin, J; Sanjurjo-Saez, M.

Implementation of an enhanced recovery after surgery program including a patient school: Impact on quality of life results

INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED. 2022; 53(12): 3987-3992 Nº de citas: 3 [doi:10.1016/j.injury.2022.09.063]

Ramirez, E; Romero-Jimenez, R; Hernandez, B; Fernandez-Pacheco, M; Calvo, A; Chamorro, E; Herrero, N; Ubeda, B; Morell, A; Ais-Larisgoi, A; Lobato-Matilla, E; Munoz, A; Casado, A; Casado, MA; Escudero-Vilaplana, V.

Evaluation of the hospital care quality perceived by patients with immune-mediated inflammatory diseases from the pharmacy service. SACVINFA study

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS. 2022; 47(12): 2020-2029 Nº de citas: 2 [doi:10.1111/jcpt.13742]

Villanueva-Bueno C; Collado-Borrell R; Escudero-Vilaplana V; Revuelta-Herrero JL; Marzal-Alfaro MB; González-Haba E; Arranz-Arija JÁ; Osorio S; Herranz-Alonso A; Sanjurjo-Saez M.

A smartphone app to improve the safety of patients undergoing treatment with oral antineoplastic agents: 4 years of experience in a university hospital.

Frontiers in Public Health. 2022; 10: 978783-978783 Nº de citas: 3 [doi:10.3389/fpubh.2022.978783]

Villanueva-Bueno C; Collado-Borrell R; Rodríguez-González CG; Escudero-Vilaplana V; Chamorro-de-Vega E; Ais-Larisgoitia A; Herranz-Alonso A; Sanjurjo-Sáez M.

Implementation and evaluation of a home pharmaceutical care model through Telepharmacy.

FARMACIA HOSPITALARIA. 2022; 46(7): 36-46

Mercadal-Orfila G; Lizeaga G; Fernández-Llamazares CM; Tortajada-Goitia B; García Cabrera E; Morillo-Verdugo R; Negro-Vega E.

Outpatient pharmaceutical care satisfaction survey through Telepharmacy during COVID-19 pandemic in Spain.

FARMACIA HOSPITALARIA. 2022; 46(7): 69-85

Morillo-Verdugo R; Collado-Borell R; Arrondo-Velasco A; Domínguez-Cantero M; Fernández-Polo A; González-Corominas E; Gutiérrez E; Linares-Alarcón A; Parro-Martín MLÁ; Rodríguez-Cabezas MÁ; Gomis-Pastor M.

Implementation of pharmaceutical care through Telepharmacy: A guide for professionals and patients.

FARMACIA HOSPITALARIA. 2022; 46(7): 115-122

Bravo-Gomez, A; Salvador-Martin, S; Zapata-Cobo, P; Sanjurjo-Saez, M; Lopez-Fernandez, LA.

Genotyping of UGT1A1*80 as an Alternative to UGT1A1*28 Genotyping in Spain

Pharmaceutics. 2022; 14(10): Nº de citas: 9 [doi:10.3390/pharmaceutics14102082]

Chamorro-de-Vega E; Romero-Jiménez R; Escudero-Vilaplana V; Ais-Larisgoitia A; Lobato Matilla ME; González CM; Menchén L; Baniandrés O; Ibares-Frias L; Lobo-Rodríguez C; Herranz-Alonso A; Sanjurjo M.

Information and Communication Technologies in Patients With Immune-Mediated Inflammatory Diseases: Cross-sectional Survey

JOURNAL OF MEDICAL INTERNET RESEARCH. 2022; 24(9): Nº de citas: 5 [doi:10.2196/37445]

Butragueno-Laiseca, L; Marco-Arino, N; Troconiz, IF; Grau, S; Campillo, N; Garcia, X; Padilla, B; Fernandez, SN; Slocker, M; Santiago, MJ.

Population pharmacokinetics of piperacillin in critically ill children including those undergoing continuous kidney replacement therapy

CLINICAL MICROBIOLOGY AND INFECTION. 2022; 28(9): Nº de citas: 6 [doi:10.1016/j.cmi.2022.03.031]

Romero-Jimenez, R; Escudero-Vilaplana, V; Chamorro-de-Vega, E; Ais-Larisgoitia, A; Lobato-Matilla, E; Somoza-Fernandez, B; Ruiz-Briones, P; Gonzalez, C; Baniandres, O; Menchen, L; Lobo-Rodriguez, C; Herranz, A; Sanjurjo, M.

Design and implementation of a mobile app for the pharmacotherapeutic follow-up of patients diagnosed with immune-mediated inflammatory diseases: eMidCare

Frontiers in Immunology. 2022; 13: Nº de citas: 3 [doi:10.3389/fimmu.2022.915578]

Escudero-Vilaplana, V; Romero-Medrano, L; Villanueva-Bueno, C; de Diago, MR; Yanez-Montesdeoca, A; Collado-Borrell, R; Campana-Montes, JJ; Marzal-Alfaro, B; Revuelta-Herrero, JL; Calles, A; Galera, M; Alvarez, R; Herranz, A; Sanjurjo, M; Artes-Rodriguez, A.

Smartphone-Based Ecological Momentary Assessment for the Measurement of the Performance Status and Health-Related Quality of Life in Cancer Patients Under Systemic Anticancer Therapies: Development and Acceptability of a Mobile App

Frontiers in Oncology. 2022; 12: [doi:10.3389/fonc.2022.880430]

Vicente-Valor, J; Escudero-Vilaplana, V; Collado-Borrell, R; Lopez-Lopez, C; Villanueva-Bueno, C; Revuelta-Herrero, JL; Ruiz-Briones, P; Somoza-Fernandez, B; Herranz, A; Sanjurjo, M.

Potential negative pharmacodynamic interaction of spironolactone and abiraterone in two prostate cancer patients

JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2022; 28(5): 1259-1263 Nº de citas: 5 [doi:10.1177/10781552221074621]

Garcia-Sanchez, S; Collado-Borrell, R; Gonzalez-Haba, E; Revuelta-Herrero, JL; Escudero-Vilaplana, V; Marzal-Alfaro, MB; Sanchez-Fresneda, MN; Mur-Mur, A; Herranz, A; Martin, M; Sanjurjo, M.

A New Methodology to Estimate Drug Cost Avoidance in Clinical Trials: Development and Application

Frontiers in Oncology. 2022; 12: Nº de citas: 3 [doi:10.3389/fonc.2022.889575]